Skip to main content
. 2014 Nov 20;15(12):1658–1666. doi: 10.4161/15384047.2014.972183

Figure 1.

Figure 1.

Generation and expression of sTRAIL specific variants. (A) Table showing the mutations in sTRAILwt leading to sTRAILDR5 (TRAIL-R2 specific) and sTRAILDR4 (TRAIL-R1 specific) variants. The TRAIL receptor specific variants were generated by site-directed mutagenesis inserting a D269H amino acid change (sTRAILDR5) and an amino acid change (S159R) to generate sTRAILDR4 in the sTRAIL ectodomain. (B) All 3 sTRAIL expression constructs were transiently transfected into 293 cells. After 24 h whole cell lysates were analyzed by Western blotting for TRAIL revealing similar expression levels for all 3 constructs. As control, expression from a conventional construct encoding membrane-bound, full-length TRAIL (FL) without hFIB, Furin CS or ILZ segments was also analyzed. EGFP transfected cells (ctrl) served as additional control. CuZnSOD was used as a loading control (C): Results of ELISA analyses for TRAIL showing the levels of secreted sTRAILwt (brown), sTRAILDR5 (red) and sTRAILDR4 (green) into the supernatant of transfected 293 cells. Results for cells transfected with the EGFP control plasmid (ctrl; gray) are also shown.